By Professor Bruce James Brew

Journal articles

Adams S; Braidy N; Bess A; Brew BJ; Grant RS; Teo C; Guillemin GJ, 2012, 'The kynurenine pathway in brain tumor pathogenesis', Cancer research, 72, pp. 5649 - 5657, http://dx.doi.org/10.1158/0008-5472.CAN-12-0549

Maruszak H; Brew BJ; Giovannoni G; Gold J, 2011, 'Could antiretroviral drugs be effective in multiple sclerosis? A case report', European Journal of Neurology, 18, http://dx.doi.org/10.1111/j.1468-1331.2011.03430.x

Jawaid A; Pradeep V; Shamsi A; Schulz PE, 2011, 'Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.', Neurology, 77, pp. 406 - 407, http://dx.doi.org/10.1212/WNL.0b013e3182246ffb

Wright E; Grund B; Robertson K; Brew B; Price R, 2011, 'Reply from the authors', Neurology, 77, pp. 407, http://dx.doi.org/10.1212/WNL.0b013e3182246fb2

Wright E; Grund B; Robertson K; Brew B; Price R, 2011, 'CARDIOVASCULAR RISK FACTORS ASSOCIATED WITH LOWER BASELINE COGNITIVE PERFORMANCE IN HIV-POSITIVE PERSONS Reply', NEUROLOGY, 77, pp. 407 - 407, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293123300026&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ng K; Kumar KR; Brew BJ; Burke D, 2011, 'Axonal excitability in viral polyneuropathy and nucleoside neuropathy in HIV patients', Journal of Neurology Neurosurgery and Psychiatry, 82, pp. 978 - 980, http://dx.doi.org/10.1136/jnnp.2009.203091

Cysique LA; Waters EK; Brew BJ, 2011, 'Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research', BMC NEUROLOGY, 11, pp. 148 - 158

Spudich S; Gisslen M; Hagberg L; Lee E; Liegler T; Brew BJ; Fuchs A; Tambussi G; Cinque P; Hecht FM; Price R, 2011, 'Central nervous system immune activation characterizes primary HIV-1 infection even in subjects with minimal cerebrospinal fluid viral burden', Journal of Infectious Diseases, 204, pp. 753 - 760, http://dx.doi.org/10.1093/infdis/jir387

Chen Y; Brew BJ; Guillemin GJ, 2011, 'Characterization of the kynurenine pathway in NSC-34 cell line: implications for amyotrophic lateral sclerosis', Journal of Neurochemistry, 118, pp. 816 - 825, http://dx.doi.org/10.1111/j.1471-4159.2010.07159.x/abstract;jsessionid=83A44016D40A402F78AD97483FD7AAFE.d02t04?systemMessage=Wiley+Online+Library+will+be+disrupted+14+May+from+10-12+BST+for+monthly+maintenance

Maruszak A; Brew BJ; Giovannoni G; Gold J, 2011, 'Could antiretroviral drugs be effective in multiple sclerosis? A case report', European Journal of Neurology, 18, pp. 110 - 111, http://dx.doi.org/10.1111/j.1468-1331.2011.03430.x/pdf

Tippett M; Cheng W; Westhorpe R; Cameron A; Brew BJ; Lewin S; Jaworowski A; Crowe S, 2011, 'Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals', PLoS One, 6, pp. 1 - 11, http://dx.doi.org/10.1371/journal.pone.0019968

McManus H; Lim P; Nolan D; Bloch M; Kiertiburanakul S; Choi J; Mulhall BP; Petoumenos K; Zhou J; Law MG; Brew BJ; Wright E, 2011, 'Does use of antiretroviral therapy regimens with high central nervous system penetration improve survival in HIV-infected adults?', HIV Medicine, 12, pp. 610 - 619, http://dx.doi.org/10.1111/j.1468-1293.2011.00938.x

Croitoru-Lamoury J; Lamoury F; Caristo M; Suzuki K; Walker DW; Takikawa O; Taylor R; Brew BJ, 2011, 'Interferon-c Regulates the Proliferation and differentiation of mesenchymal stem cells via activation of indoleamine 2,3 dioxygenase (IDO)', PLoS One, 6, pp. 1 - 13, http://dx.doi.org/10.1371/journal.pone.0014698

Rahman A; Brew BJ; Guillemin GJ, 2011, 'Lead dysregulates serine/threonine protein phosphatases in human neurons', Neurochemical Research, 36, pp. 195 - 204, http://dx.doi.org/10.1007/s11064-010-0300-6

Wu W; Cullen K; Stankovic R; Bao S; Bell J; Brew B; Guillemin G, 2011, 'P4‐035: Quinolinic acid in HIV‐1‐associated dementia with pathogenetic processes distinct from Alzheimer disease', Alzheimer's & Dementia, 7, http://dx.doi.org/10.1016/j.jalz.2011.05.2055

Hillman R; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews GV; Brew BJ; Milliken S; Botes LP, 2011, 'Participants' perspectives of high resolution anoscopy', Sexual Health, 8, pp. 255 - 256, http://search.informit.com.au/documentSummary;dn=026919938891985;res=IELHEA

Botes LP; Jin F; Bourne CP; Pett SL; Marriott D; Carr AD; Cooper DA; Matthews G; Brew BJ; Hillman R, 2011, 'Participants' perspectives of self-collected anal cytological swabs', Sexual Health, 8, pp. 257 - 258, http://search.informit.com.au/documentSummary;dn=026957204834502;res=IELHEA

Maher A; Cysique LA; Brew BJ; Rae CD, 2011, 'Statistical integration of 1H NMR and MRS data from difefrent biofluids and tissues enhances recovery of biological information from individuals with HIV-1 infection', Journal of Proteome Research, 10, pp. 1737 - 1745, http://dx.doi.org/10.1021/pr1010263

Cysique LA; Bain MP; Brew BJ; Murray JM, 2011, 'The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future', Sexual Health, 8, pp. 541 - 550, http://search.informit.com.au/documentSummary;dn=535898181780976;res=IELHEA

Tisch S; Brew BJ, 2010, 'HIV, HAART, and parkinson's disease: Co-incidence or pathogenetic link?', Movement Disorders, 25, pp. 2257 - 2258, http://dx.doi.org/10.1002/mds.23277

Guillemin GJ; Rahman A; Ting K; Cullen KM; Braidy N; Chung RS; Wu W; Brew BJ, 2010, 'INVOLVEMENT OF THE KYNURENINE PATHWAY IN ALZHEIMER'S DISEASE', JOURNAL OF NEUROCHEMISTRY, 115, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281812600096&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhou L; Diefenbach E; Crossett B; Tran SL; Ng T; Rizos H; Rua R; Wang B; Kapur A; Gandhi K; Brew BJ; Saksena NK, 2010, 'First evidence of overlaps between HIV-associated dementia (HAD) and non-viral neurodegenerative diseases: Proteomic analysis of the frontal cortex from HIV+ patients with and without dementia', Molecular Neurodegeneration, 5, http://dx.doi.org/10.1186/1750-1326-5-27

Brew BJ; Cysique LA, 2010, 'Editorial: Alzheimer disease and HIV: A tangled story', Neurology, 75, pp. 105 - 106, http://dx.doi.org/10.1212/WNL.0b013e3181e7b6a4

Hagberg L; Cinque P; Gisslen M; Brew BJ; Spudich S; Bestetti A; Price RW; Fuchs D, 2010, 'Cerebrospinal fluid neopterin: An informative biomarker of central nervous system immune activation in HIV-1 infection', AIDS Research and Therapy, 7, http://dx.doi.org/10.1186/1742-6405-7-15

McArthur JC; Brew BJ, 2010, 'HIV-associated neurocognitive disorders: Is there a hidden epidemic?', AIDS, 24, pp. 1367 - 1370, http://dx.doi.org/10.1097/QAD.0b013e3283391d56

Brew BJ, 2010, 'HIV and the Acquired Immunodeficiency Syndrome: An Overview of Neurological Complications', , pp. 340 - 341, http://dx.doi.org/10.1002/9781444317008.ch92

Brew BJ, 2010, 'HIV-Associated Cerebral Opportunistic Infections', , pp. 356 - 359, http://dx.doi.org/10.1002/9781444317008.ch97

Brew BJ, 2010, 'HIV-Associated Lymphoma: Neurologic Complications', , pp. 360 - 361, http://dx.doi.org/10.1002/9781444317008.ch98

Cherry CL; Affandi JS; Brew BJ; Creighton J; Djauzi S; Hooker DJ; Imran D; Kamarulzaman A; Kamerman P; McArthur JC; Moore RD; Price P; Smyth K; Tan IL; Vanar S; Wadley A; Wesselingh SL; Yunihastuti E, 2010, 'Hepatitis C seropositivity is not a risk factor for sensory neuropathy among patients with HIV', Neurology, 74, pp. 1538 - 1542, http://dx.doi.org/10.1212/WNL.0b013e3181dd436d

Brew BJ, 2010, 'Neurodegeneration in the HAART era', RETROVIROLOGY, 7, pp. 3 - 3, http://dx.doi.org/10.1186/1742-4690-7-S1-I7

Brew BJ, 2010, 'Benefit or toxicity from neurologically targeted antiretroviral therapy?', Clinical Infectious Diseases, 50, pp. 930 - 932, http://dx.doi.org/10.1086/650744

Lifson A; Belloso W; Davey R; Duprez D; Gatell J; Hoy J; Krum E; Nelson R; Pedersen C; Perez G; Price R; Prineas R; Rhame F; Sampson J; Worley J, 2010, 'Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials', HIV Clinical Trials, 11, pp. 205 - 219, http://dx.doi.org/10.1310/hct1104-205

Davies NWS; Guillemin G; Brew BJ, 2010, 'Tryptophan, neurodegeneration and HIV-associated neurocognitive disorder', International Journal of Tryptophan Research, 3, pp. 121 - 140, http://dx.doi.org/10.4137/ijtr.s4321

Lim CK; Brew BJ; Sundaram G; Guillemin GJ, 2010, 'Understanding the roles of the kynurenine pathway in multiple sclerosis progression', International Journal of Tryptophan Research, 3, pp. 157 - 167, http://dx.doi.org/10.4137/ijtr.s4294

Cherry C; Brew B; Downs C; Gregorio‐King C; Cooke I; Rennie G; Goodchild C, 2010, '270 FLUPIRTINE AS AN ADJUNCT TO OPIOID ANALGESIA IN HIV NEUROPATHY PAIN', European Journal of Pain Supplements, 4, pp. 78 - 78, http://dx.doi.org/10.1016/s1754-3207(10)70275-3

Ng K; Kumar K; Brew B; Burke D, 2010, '4. The electrophysiological features of HIV peripheral neuropathy', Clinical Neurophysiology, 121, pp. e2 - e2, http://dx.doi.org/10.1016/j.clinph.2009.10.024

Brew B, 2010, 'A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease', Neurobehavioral HIV Medicine, pp. 59 - 59, http://dx.doi.org/10.2147/nbhiv.s7167

Lee M; Ting KK; Adams S; Brew BJ; Chung R; Guillemin GJ, 2010, 'Characterisation of the expression of NMDA receptors in human astrocytes', PLoS One, 5, pp. e14123

Guillemin GJ; Rahman A; Ting KK; Cullen K; Braidy N; Chung R; Wu W; Brew BJ, 2010, 'P4‐002: Involvement of the Kynurenine Pathway in Alzheimer's Disease', Alzheimer's & Dementia, 6, http://dx.doi.org/10.1016/j.jalz.2010.08.063

Brew BJ; Davies NWS; Cinque P; Clifford D; Nath A, 2010, 'Progressive multifocal leukoencephalopathy and other forms of JC virus disease', Nature Reviews Neuroscience, 6, pp. 667 - 679

Dunbar M; Murray JM; Cysique LA; Brew BJ; Jeyakumar V, 2010, 'Simultaneous classification and feature selection via convex quadratic programming with application to HIV-associated neurocognitive disorder assessment', European Journal of Operational Research, 206, pp. 470 - 478, http://www.sciencedirect.com/science/article/B6VCT-4YM7FH3-4/2/a3b9972e52fd64b1f7b5439ecdb15184

Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H, 2009, 'Amyloid and tau cerebrospinal fluid biomarkers in HIV infection', BMC Neurology, 9, http://dx.doi.org/10.1186/1471-2377-9-63

Joseph J; Clifford D; Douglas SD; Fox H; Gendelman HE; Gonzalez-Scarano F; Grant I; Major E; McArthur J, 2009, 'Planning Future Strategies for Domestic and International NeuroAIDS Research, July 24-25, 2008', JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 4, pp. 283 - 297, http://dx.doi.org/10.1007/s11481-009-9159-1

Churchill MJ; Wesselingh SL; Cowley D; Pardo CA; McArthur JC; Brew BJ; Gorry PR, 2009, 'Extensive astrocyte infection is prominent in human immunodeficiency virus - associated dementia', Annals of Neurology, 66, pp. 253 - 258, http://dx.doi.org/10.1002/ana.21697

Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sherieff S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain (Journal of Virology (2009) 83, 11, (5430-5441))', Journal of Virology, 83, pp. 7794, http://dx.doi.org/10.1128/JVI.01082-09

Gray L; Roche M; Churchill MJ; Sterjovski J; Ellett A; Poumbourios P; Sheffief S; Wang B; Saksena N; Purcell DFJ; Wesselingh S; Cunningham AL; Brew BJ; Gabuzda D; Gorry PR, 2009, 'Tissue-specific sequence alterations in the human immunodeficiency virus type 1 envelope favoring CCR5 usage contribute to persistence of dual-tropic virus in the brain', Journal of Virology, 83, pp. 5430 - 5441, http://dx.doi.org/10.1128/JVI.02648-08

Tan IL; Brew BJ, 2009, 'Possible JCV granular cell neuronopathy in a patient with HIV infection', Neurology, 73, pp. 1598 - 1599, http://dx.doi.org/10.1212/WNL.0b013e3181c0d6cb

Brew BJ; Gisslen M; Pemberton L; Cinque P; Hagberg L; Price RW; Blennow K; Spudich S, 2009, '110. CSF t-tau, p-tau and Amyloid Beta 1-42 in HIV Infection', Journal of Clinical Neuroscience, 16, pp. 464 - 464, http://dx.doi.org/10.1016/j.jocn.2008.07.009

Brew B; Tisch S, 2009, '20. Parkinsonism in HIV-infected patients on highly active antiretroviral therapy', Journal of Clinical Neuroscience, 16, pp. 1531 - 1531, http://dx.doi.org/10.1016/j.jocn.2009.07.045

Sher L; Cramer D; Grinyer J; Hall BM; Brayman K; Mirmira R, 2009, 'Editorial introductions', Current Opinion in Organ Transplantation, 14

Back to profile page